Effect of ovariectomy and androgen on phenobarbital induction of hepatic CYP2B1 and CYP2B2 in sprague-dawley rats

Drug Metabolism and Disposition

Volumn 25, Issue 8, 1997, Pages 994-1000

  Chang, Thomas K H ^b   Anderson, Mellissa D ^b   Bandiera, Stelvio M ^b   Bellward, Gail D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CYTOCHROME P450; ENZYME; IODINE 125; OXYGENASE; PHENOBARBITAL; RESORUFIN; TESTOSTERONE; TESTOSTERONE ENANTATE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER MICROSOME; MALE; NONHUMAN; OVARIECTOMY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SEX DIFFERENCE;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP2B1; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; FEMALE; LIVER; MALE; OVARIECTOMY; OVARY; PHENOBARBITAL; RATS; RATS, SPRAGUE-DAWLEY; STEROID HYDROXYLASES; TESTOSTERONE;

ANIMALIA;

EID: 0030835437     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. D. J. Waxman and T. K. H. Chang: Hormonal regulation of liver cytochrome P450 enzymes. In "Cytochrome P450: Structure, Mechanism, and Biochemistry" 2nd Ed. (P. R. Ortiz de Montellano, ed.), pp. 391-417, Plenum Press, New York, 1995.
2. G. S. Tannenbaum and J. B. Martin: Evidence for an endogenous ultradian rhythm governing growth hormone secretion in the rat. Endocrinology 98, 562-570 (1976).
3. R. G. Clark, L. M. S. Carlsson, and I. C. A. F. Robinson: Growth hormone secretory profiles in conscious female rats. J. Endocrinol. 114, 399-407 (1987).
4. E. T. Morgan, C. MacGeoch, and J. A. Gustafsson: Hormonal and developmental regulation of expression of the hepatic microsomal steroid 16α-hydroxylase cytochrome P-450 apoprotein in the rat. J. Biol. Chem. 260, 11895-11898 (1985).
5. R. Kato, Y. Yamazoe, M. Shimada, N. Murayama, and T. Kamataki: Effect of growth hormone and ectopic transplantation of pituitary gland on sex-specific forms of cytochrome P-450 and testosterone and drug oxidations in rat liver. J. Biochem. 100, 895-902 (1986).
6. D. J. Waxman, N. A. Pampori, P. A. Ram, A. K. Agrawal, and B. H. Shapiro: Interpulse interval in circulating growth hormone patterns regulates sexually dimorphic expression of hepatic cytochrome P450. Proc. Natl. Acad. Sci. USA 88, 6868-6872 (1991).
7. C. MacGeoch, E. T. Morgan, J. R. Halpert, and J. A. Gustafsson: Purification, characterization, and pituitary regulation of the sex-specific cytochrome P-450 15β-hydroxylase from liver microsomes of untreated female rats. J. Biol. Chem. 259, 15433-15439 (1984).
8. P. E. Thomas, L. M. Reik, D. E. Ryan, and W. Levin: Regulation of three forms of cytochrome P-450 and epoxide hydrolase in rat liver microsomes: effects of age, sex and induction. J. Biol. Chem. 256, 1044-1052 (1981).
9. Y. Yamazoe, M. Shimada, N. Murayama, and R. Kato: Suppression of levels of phenobarbital-inducible rat liver cytochrome P-450 by pituitary hormone. J. Biol. Chem. 262, 7423-7426 (1987).
10. F. P. Guengerich, G. A. Dannan, S. T. Wright, M. V. Martin, and L. S. Kaminsky: Purification and characterization of liver microsomal cytochromes P-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes from rats treated with phenobarbital or β-naphthoflavone. Biochemistry 21, 6019-6030 (1982).
11. D. J. Waxman, G. A. Dannan, and F. P. Guengerich: Regulation of rat hepatic cytochrome P-450: age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes. Biochemistry 24, 4409-4417 (1985).
12. A. D. Rodrigues, P. R. Waddell, E. Ah-Sing, B. A. Morris, C. R. Wolf, and C. Ioannides: Induction of the rat hepatic microsomal mixed-function oxidases by 3 imidazole-containing antifungal agents: selectivity for the cytochrome P-450IIB and P-450III families of cytochrome P-450. Toxicology 50, 283-301 (1988).
13. K. A. Hostetler, S. A. Wrighton, D. T. Molowa, P. E. Thomas, W. Levin, and P. S. Guzelian: Coinduction of multiple hepatic cytochrome P-450 proteins and their mRNAs in rats treated with imidazole antimycotic agents. Mol. Pharmacol. 35, 279-285 (1989).
14. J. Pan, J. Y. Hong, B. L. Ma, S. M. Ning, S. R. Paranawithana, and C. S. Yang: Transcriptional activation of cytochrome P450 2B1/2 gene in rat liver by diallyl sulfide, a compound derived from garlic. Arch. Biochem. Biophys. 302, 337-342 (1993).
15. G. A. Dannan, F. P. Guengerich, L. S. Kaminsky, and S. D. Aust: Regulation of cytochrome P-450. Immunochemical quantitation of eight isozymes in liver microsomes of rats treated with polybrominated biphenyl congeners. J. Biol. Chem. 258, 1282-1288 (1983).
16. A. Parkinson, S. H. Safe, L. W. Robertson, P. E. Thomas, D. E. Ryan, L. M. Reik, and W. Levin: Immunochemical quantitation of cytochrome P-450 isozymes and epoxide hydrolase in liver microsomes from polychlorinated or polybrominated biphenyl-treated rats: a study of structure activity relationships. J. Biol. Chem. 258, 5967-5976 (1983).
17. K. Connor, S. Safe, C. R. Jefcoate, and M. Larsen: Structure-dependent induction of CYP2B by polychlorinated biphenyl congeners in female Sprague-Dawley rats. Biochem. Pharmacol. 50, 1913-1920 (1995).
18. N. Murayama, M. Shimada, Y. Yamazoe, and R. Kato: Difference in the susceptibility of two phenobarbital-inducible forms, P450IIB1 and P450IIB2, to thyroid hormone- and growth hormone-induced suppression in rat liver: phenobarbital-inducible P450IIB2 suppression by thyroid hormone acting directly, but not through the pituitary system. Mol. Pharmacol. 39, 811-817 (1991).
19. M. C. Larsen, P. B. Brake, D. Parmar, and C. R. Jefcoate: The induction of five rat hepatic P450 cytochromes by phenobarbital and similarly acting compounds is regulated by a sexually dimorphic, dietary-dependent endocrine factor that is highly strain specific. Arch. Biochem. Biophys. 315, 24-34 (1994).
20. N. M. Wilson, M. Christou, and C. R. Jefcoate: Differential expression and function of three closely related phenobarbital-inducible cytochrome P-450 isozymes in untreated rat liver. Arch. Biochem. Biophys. 256, 407-420 (1987).
21. R. A. Lubet, R. W. Nims, K. H. Dragnev, C. R. Jones, B. A. Diwan, D. E. Devor, J. M. Ward, M. S. Miller, and J. M. Rice: A markedly diminished pleiotropic response to phenobarbital and structurally-related xenobiotics in Zucker rats in comparison with F344/NCr or DA rats. Biochem. Pharmacol. 43, 1079-1087 (1992).
22. R. A. Blouin, A. M. Bandyopadhyay, I. Chaudhary, L. W. Robertson, B. Gemzik, and A. Parkinson: Cytochrome P450 2B enzyme (CYP2B) induction defect following phenobarbital treatment in the fa/fa Zucker rat: Molecular characterization. Arch. Biochem. Biophys. 303, 313-320 (1993).
23. Y. Yamazoe, M. Shimada, N. Murayama, K. Yamauchi, and R. Kato: Alteration of hepatic drug metabolizing activities and contents of cytochrome P-450 isozymes by neonatal monosodium glutamate treatment. Biochem. Pharmacol. 37, 1687-1691 (1988).
24. B. H. Shapiro, N. A. Pampori, D. P. Lapenson, and D. J. Waxman: Growth hormone-dependent and -independent sexually dimorphic regulation of phenobarbital-induced hepatic cytochromes P450 2B1 and 2B2. Arch. Biochem. Biophys. 312, 234-239 (1994).
25. E. G. Schuetz, J. D. Schuetz, B. May, and P. S. Guzelian: Regulation of cytochrome P-450b/e and P-450p gene expression by growth hormone in adult rat hepatocytes cultured on a reconstituted basement membrane. J. Biol. Chem. 265, 1188-1192 (1990).
26. D. J. Waxman, J. J. Morrissey, S. Naik, and H. O. Jauregui: Phenobarbital induction of cytochromes P-450. High-level long-term responsiveness of primary rat hepatocyte cultures to drug induction, and glucocorticoid dependence of the phenobarbital response. Biochem. J. 271, 113-119 (1990).
27. P. Bullock, B. Gemzik, D. Johnson, P. Thomas, and A. Parkinson: Evidence from dwarf rats that growth hormone may not regulate the sexual differentiation of liver cytochrome P450 enzymes and steroid 5α-reductase. Proc. Natl. Acad. Sci. USA 88, 5227-5231 (1991).
28. H. M. Charlton, R. G. Clark, I. C. A.F. Robinson, A. E. Portergoff, B. S. Cox, C. Bugnon, and B. A. Bloch: Growth hormone-deficient dwarfism in the rat: A new mutation. J. Endocrinol. 119, 51-58 (1988).
29. M. C. Larsen, and C. R. Jefcoate: Phenobarbital induction of CYP2B1, CYP2B2, and CYP3A1 in rat liver: Genetic differences in a common regulatory mechanism. Arch. Biochem. Biophys. 321, 467-476 (1995).
30. B. J. Cadario, G. D. Bellward, S. Bandiera, T. K. H. Chang, W. W. W. Ko, E. Lemieux, and R. C. K. Pak: Imprinting of hepatic microsomal cytochrome P-450 enzyme activities and cytochrome P-450IIC11 by peripubertal administration of testosterone in female rats. Mol. Pharmacol. 41, 981-988 (1992).
31. T. K. H. Chang and G. D. Bellward: Peripubertal androgen imprinting of rat hepatic cytochrome P450 2C11 and steroid 5α-reductase: pretranslational regulation and impact on microsomal drug activation. J. Pharmacol. Exp. Ther. 278, 1383-1391 (1996).
32. A. K. Agrawal, and B. H. Shapiro: Phenobarbital induction of hepatic CYP2B1 and CYP2B2: pretranscriptional and post-transcriptional effects of gender, adult age, and phenobarbital dose. Mol. Pharmacol. 49, 523-531 (1996).
33. A. Y. H. Lu, and W. Levin: Partial purification of cytochrome P-450 and P-448 from rat liver microsomes. Biochem. Biophys. Res. Commun. 46, 1334-1339 (1972).
34. S. M. Bandiera, S. M. Torok, S. Lin, M. A. Ramsay, and R. J. Norstrom: Catalytic and immunologic characterization of hepatic and lung cytochromes P450 in the polar bear. Biochem. Pharmacol. 49, 1135-1146 (1995).
35. A. Wong and S. M. Bandiera: Inductive effect of Telazol® on hepatic expression of cytochrome P450 2B in rats. Biochem. Pharmacol. 52, 735-742 (1996).
36. 4. Nature (Lond.) 227, 680-685 (1970).
37. H. Towbin, T. Staehelin, and J. Gordon: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acacl. Sci. USA 76, 4350-4354 (1979).
38. D. J. Waxman: P450-catalyzed steroid hydroxylation: Assay and product identification by thin-layer chromatography. Methods Enzymol. 206, 462-476 (1991).
39. A. J. Sonderfan and A. Parkinson: Inhibition of steroid 5α-reductase and its effects on testosterone hydroxylation by rat liver microsomal cytochrome P-450. Arch. Biochem. Biophys. 265, 208-218 (1988).
40. M. D. Burke and R. T. Mayer: Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metab. Dispos. 2, 583-588 (1974).
41. 19 steroids by five highly purified and reconstituted rat hepatic cytochrome P-450 isozymes. J. Biol. Chem. 258, 8839-8847 (1983).
42. T. Chang, M. Levine, S. M. Bandiera, and G. D. Bellward: Selective inhibition of rat hepatic microsomal cytochrome P-450. I. Effect of the in vivo administration of cimetidine. J. Pharmacol. Exp. Ther. 260, 1441-1449 (1992).
43. T. Omura and R. Sato: The carbon monoxide binding pigment of liver microsomes. II. Solubilization, purification, and properties. J. Biol. Chem. 239, 2379-2385 (1964).
44. D. J. Waxman, D. P. Lapenson, S. S. Park, C. Attisano, and H. V. Gelboin: Monoclonal antibodies inhibitory to rat hepatic cytochromes P-450: P-450 form specificities and use as probes for cytochrome P-450-dependent steroid hydroxylations. Mol. Pharmacol. 32, 615-624 (1987).
45. P. V. Nerurkar, S. S. Park, P. E. Thomas, R. W. Nims, and R. A. Lubet: Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P450 1A2 and 2B, respectively, in the rat and mouse. Biochem. Pharmacol. 46, 933-943 (1993).
46. M. D. Burke, S. Thompson, R. J. Weaver, C. R. Wolf, and R. T. Mayer: Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem. Pharmacol. 48, 923-936 (1994).
47. R. A. Lubet, R. T. Mayer, J. W. Cameron, R. W. Nims, M. D. Burke, T. Wolff, and F. P. Guengerich: Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Arch. Biochem. Biophys. 238, 43-48 (1985).
48. D. R. Dutton and A. Parkinson: Reduction of 7-alkoxyresorufins by NADPH-cytochrome P450 reductase and its differential effects on their O-dealkylation by rat liver microsomal cytochrome P450. Arch. Biochem. Biophys. 268, 617-629 (1989).
49. B. H. Shapiro, J. N. MacLeod, N. A. Pampori, J. J. Morrissey, D. P. Lapenson, and D. J. Waxman: Signalling elements in the ultradian rhythm of circulating growth hormone regulating expression of sex-dependent forms of hepatic cytochrome P450. Endocrinology 125, 2935-2944 (1989).
50. N. A. Pampori, A. K. Agrawal, D. J. Waxman, and B. H. Shapiro: Differential effects of neonatally administered glutamate of the ultradian pattern of circulating growth hormone regulating expression of sex-dependent forms of cytochrome P450. Biochem. Pharmacol. 41, 1299-1309 (1991).
51. J. O. Jansson, and L. A. Frohman: Inhibitory effect of the ovaries on neonatal androgen imprinting of growth hormone secretion in female rats. Endocrinology 121, 1417-1423 (1987).
52. J. O. Jansson, S. Ekberg, O. G. P. Isaksson, and S. Eden: Influence of gonadal steroids on age- and sex-related secretory patterns of growth hormone in the rat. Endocrinology 114, 1287-1294 (1984).
53. J. O. Jansson, S. Ekberg, O. Isaksson, A. Mode, and J. A. Gustafsson: Imprinting of growth hormone secretion, body growth, and hepatic steroid metabolism by neonatal testosterone. Endocrinology 117, 1881-1889 (1985).
54. B. H. Shapiro, N. A. Pampori, P. A. Ram, and D. J. Waxman: Irreversible suppression of growth hormone-dependent cytochrome P450 2C11 in adult rats neonatally treated with monosodium glutamate. J. Pharmacol. Exp. Ther. 265, 979-984 (1993).
55. D. J. Waxman, A. Ko, and C. Walsh: Regioselectivity and stereoselectivity of androgen hydroxylations catalyzed by cytochrome P-450 isozymes purified from phenobarbital-induced rat liver. J. Biol. Chem. 258, 11937-11947 (1983).
56. T. Nakajima, E. Elovaara, S. S. Park, H. V. Gelboin, E. Hietanen, and H. Vainio: Monoclonal antibody-directed characterization of benzene, ethoxyresorufin and pentoxyresorufin metabolism in rat liver microsomes. Biochem. Pharmacol. 40, 1255-1261 (1990).
57. R. R. Meehan, L. M. Forrester, K. Stevenson, N. D. Hastie, A. Buchmann, H. W. Kunz, and C. R. Wolf: Regulation of phenobarbital-inducible cytochrome P-450s in rat and mouse liver following dexamethasone administration and hypophysectomy. Biochem. J. 254, 789-797 (1988).
58. D. R. Nelson, L. Koymans, T. Kamataki, J. J. Stegeman, R. Feyereisen, D. J. Waxman, M. R. Waterman, O. Gotoh, M. J. Coon, R. W. Estabrook, I. C. Gunsalus, and D. W. Nebert: P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6, 1-42 (1996).